TABLE 4. Percentage of the Sample Receiving Diagnostic Tests According to Group.
% of CGI (n = 46) |
% of CP (n = 43) |
|
---|---|---|
Blood work | ||
White blood cell count | 43.5 | 60.5 |
Hemoglobin | 45.7 | 60.5 |
Erythrocyte sedimentation rate | 30.4 | 14.0 |
C-reactive protein | 23.9 | 4.7 |
Alanine aminotransferase | 43.5 | 16.3 |
Aspartate aminotransferase | 45.7 | 16.3 |
γ glutamyl-transpeptidase | 15.2 | 2.3 |
Alkaline phosphatase | 43.5 | 16.3 |
Total bilirubin | 39.1 | 16.3 |
Direct bilirubin | 10.9 | 0 |
Amylase | 17.4 | 0 |
Lipase | 15.2 | 0 |
Blood urea nitrogen | 45.7 | 16.3 |
Creatinine | 43.5 | 16.3 |
Inflammatory bowel disease markers |
4.4 | 0 |
Helicobacter pylori antibodies | 23.9 | 16.3 |
Urine tests | ||
Urinalysis | 21.7 | 37.2 |
Urine culture | 8.7 | 11.6 |
Stool studies | ||
Guaiac | 23.9 | 4.7 |
Campylobacter, Shigella, Salmonella cultures |
8.7 | 7.0 |
Giardia, Cryptosporidium antigens | 13.0 | 4.7 |
Ova and parasites | 19.6 | 11.6 |
Clostridium difficile toxin | 2.2 | 0 |
Breath testing | ||
Lactose breath hydrogen test | 6.5 | 0 |
Helicobacter pylori breath test | 10.9 | 2.3 |
Diagnostic imaging | ||
Abdominal ultrasound | 23.9 | 4.7 |
Plain radiograph of the abdomen | 4.4 | 14.0 |
Upper gastrointestinal radiographic series with/without small bowel follow-through |
17.4 | 0 |
Endoscopy procedures (only able to occur in tertiary care) | ||
Esophagogastroduodenoscopy or upper endoscopy |
17.4 | NA |
Colonoscopy | 2.2 | NA |
Flexible sigmoidoscopy | 0 | NA |
NA indicates not applicable to the CP group.